Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of HSK21542 Injection in Hemodialysis Patients With Chronic Kidney Disease-Associated Pruritus
CTR20213394Phase 3Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Apr 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of hsk21542 in chronic kidney disease (CKD), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd.. Started Apr 2022; status: completed.
02
Drugs
hsk21542
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20213394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213394.